Philips, AWS expand partnership on digital pathology in the cloud

Philips (NYSE: PHG) + today announced an expanded partnership with Amazon Web Services (AWS) based around digital pathology in the cloud.

The two initially linked up about a year ago, inking a deal to develop generative AI applications. This partnership centered around Philips’ imaging archiving and communications system. It wasn’t the first time a medtech giant linked up with AWS, as GE HealthCare and Baxter also announced similar deals in the past.

Today’s announcement aims to unite Philips’ expertise in the digitization of pathology with AWS’ leadership in scalable, secure cloud solutions.

Together, Philips and AWS hope to advance digital pathology. They want to help labs efficiently store, manage and analyze growing volumes of digital pathology data. This would, in turn, enable the adoption of digital workflows to increase productivity.

Additionally, Philips says patholog…

Read more
  • 0

Philips, SyntheticMR partner on AI-based brain imaging

The Smart Quant Neuro 3D brain imaging platform. [Image courtesy of Philips/SyntheticMR]Philips (NYSE: PHG) + announced today that it launched its Smart Quant Neuro 3D for brain disorder diagnosis and therapy.

The company unveiled the system at ECR2024 in partnership with Swedish MRI software solutions company SyntheticMR. Smart Quant Neuro 3D provides objective decision support for disorders like multiple sclerosis (MS), traumatic brain injury (TBI), and dementia.

According to a news release, the technology provides auto-measurement of various brain tissues. This enhances decision support of rain disease and helps assess progression and monitor the effect of therapy. Its analysis of myelin volumes also provides objective assessments for traumatic brain injuries. Previously, these were only diagnosed through symptom-based tests, Philips says.

The platform combines Philips’ AI-based SmartSmeed image-reconstruc…

Read more
  • 0

Philips unveils new AI-enabled CT imaging tech

The CT 5300 system. [Image courtesy of Philips]Philips (NYSE: PHG) + announced today that it launched its CT 5300 system, a flexible X-ray CT platform with advanced AI capabilities.

Amsterdam-based Philips says the system increases diagnostic confidence, streamlines workflow efficiency and maximizes system up-time. It helps to improve overall patient outcomes and department productivity. Philips unveiled the new system at ECR2024.

CT 5300 meets advanced diagnostic imaging requirements for cardiac care patient guidelines, according to Philips. The company says it also offers utility in other challenging areas like trauma care and interventional procedures. Additionally, the system features virtual tools for real-time collaboration and clinical/technical support.

Philips also designed the system for more accessibility and lower energy consumption.

With Nanopanel Precise, the company’s first detector buil…

Read more
  • 0

Philips tabs Stryker controller as next CFO

Philips proposed to appoint Charlotte Hanneman as its next CFO. [Image courtesy of Philips]Philips (NYSE: PHG) + announced today that it proposes to appoint Charlotte Hanneman as a member of its management board as chief financial officer (CFO).

The Dutch medtech giant proposed to make the appointment effective on Oct. 1, 2024. It must submit its proposal to the annual general meeting of shareholders scheduled for May 7, 2024.

Philips expects to have Hanneman join as a member of its executive committee on June 1, 2024. This begins her induction and transition into the role as she succeeds current CFO Abhijit Bhattacharya on Oct. 1, following his retirement.

Roy Jakobs, CEO of Royal Philips said: “I would like to thank Abhijit for his significant contribution to the transformation of Philips into a health technology company. His dedication and leadership have made a major impact throughout his long 37-year career in…

Read more
  • 0

Philips launches new Azurion neuro biplane system for neurovascular interventions

The Azurion neuro biplane system. [Image courtesy of Philips]Philips (NYSE: PHG) + announced today that it made major enhancements to its Azurion image-guided therapy system with a new launch.

The Amsterdam-based medtech giant unveiled its new Azurion neuro biplane system at ECR 2024. It designed the system to streamline neurovascular procedures and help care teams make the right decisions and do so faster. This enables the treatment of more patients and better outcomes.

Philips’ new interventional system features enhanced 2D and 3D imaging and X-ray detector positioning flexibility. The company believes it enhances both the staff and patient experience and contributes to lower costs for care.

Azurion smooths and optimizes procedure workflows for confident diagnosis and precision treatment. It utilizes the company’s latest Neuro Suite software and services to provide a fully integrated solution. New fea…

Read more
  • 0

Philips unveils radiation-free imaging tech that uses light instead of X-ray

The LumiGuide imaging system in use. [Image courtesy of Philips]Philips (NYSE: PHG) + announced the introduction of its new LumiGuide imaging technology that uses light to help navigate blood vessels.

The company has now made LumiGuide — first used in late 2023 to treat patients in the Netherlands — available to major aortic centers that perform complex aortic repairs in the U.S. and Europe.

LumiGuide offers radiation-free technology, which Philips believes could provide game-changing benefits for complex aortic procedures. Philips said that, for decades, clinicians could only rely on X-ray imaging to guide devices through blood vessels in endovascular procedures. However, in addition to potentially harmful radiation, X-ray only produces 2D black and white images.

With more complex procedures, like aortic aneurysm repair, cases also take more time. That leads to higher radiation doses.

LumiGuide uses light r…

Read more
  • 0

Philips wins FDA nod for latest IntelliVue patient monitor software including Sounds alarm package

The IntelliVue software with Patient Sounds in use at a patient’s bedside. [Image courtesy of Philips]Philips (NYSE: PHG) + announced today that it received FDA 510(k) clearance for its latest IntelliVue patient monitor software.

The latest IntelliVue technology includes several new solutions, including the Philips Sounds alarm package. This clearance means the alarm package now has availability in the U.S. and more than 200 countries worldwide.

Philips worked with clinicians and sound experts to provide a new perspective to acute patient monitor alarms. Together with sound design group SenSound, the company looked to soften and round alarm tones. It also aimed to adjust alarm intervals to more gently signal status or request action using more soothing alarm sounds.

“While alarms in acute care settings must be effective, they should be sensible, informative, and respectful of the surrounding environment and t…

Read more
  • 0

Philips has a serious BrightView recall due to potential falling components

The BrightView imaging system. [Image from Philips]The FDA issued a Class I recall — the most serious kind — for the Philips (NYSE: PHG) + BrightView SPECT imaging systems.

In December 2023, Philips notified customers about a potential issue with BrightView systems (including BrightView, BrightView X and BrightView XCT). Under specific circumstances, the detector may move downward due to a potential component (lead screw) failure. This comes with a risk of contacting the patients, according to a Philips spokesperson.

The FDA described the issue by saying the “detector may unexpectedly fall due to a component failure.” According to the agency, if a detector is positioned below center of the system gantry, there is the potential for abrasion, contusion, laceration and/or fracture to the patient’s lower limbs, as well as an interruption to normal system operation. If the detector is positioned above the cen…

Read more
  • 0

FDA clears latest Philips TEE transducer for cardiac care

The Mini TEE transducer in use with a younger patient. [Image courtesy of Philips]Philips (NYSE: PHG) + announced today that the FDA granted 510(k) clearance to its latest TEE transducer technology.

The Dutch medtech giant designed its transesophageal echocardiography (TEE) ultrasound transducer to help in the early diagnosis of structural heart disease. TEE helps cardiologists by providing highly detailed images of the heart and its internal structures.

Additionally, TEE can help in minimally invasive heart surgeries and procedures. That includes the treatment of damaged heart valves and congenital heart defects.

Philips said the latest TEE system, its X11-4t Mini 3D transducer, opens up the treatment option to a much wider population. Previously, pediatric patients, adults at risk of complications and other complex cases couldn’t access the treatment because 3D TEE proved too large. The new Mini transducer …

Read more
  • 0

Philips discontinues certain CPAP product lines after recall saga, stock sinks on Q4 results

The now-discontinued DreamStation Go portable CPAP system. [Image from Philips]Philips (NYSE: PHG) + has discontinued the U.S. sales of several respiratory device product lines, including one from its much-maligned CPAP portfolio.

The Dutch medtech giant began dealing with troubles within its Respironics business in mid-2021. Philips recalled more than 5 million devices since then due to the dangerous degradation of sound abatement foam. The FDA logged more than 100,000 reports of problems related to the recall. At least 385 related to deaths.

While the company continues to work through its remediation process, more light has been shed on how the recall unfolded as it did. ProPublica and the Pittsburgh Post-Gazette first reported that Philips withheld its CPAP issues from the FDA for years. The reporting later revealed CEO Roy Jakobs’ apparent knowledge of the ongoing issues and alleged approval of the sale of defective d…

Read more
  • 0

Report: Concerning chemicals found in replacement Philips CPAPs

The Philips DreamStation 2 continuous positive airway pressure (CPAP) device [Photo courtesy of Philips]Replacement machines issued by Philips (NYSE: PHG) + amid its respiratory device recall may have more issues, according to ProPublica and the Pittsburgh Post-Gazette.

Philips Respironics has recalled more than 5 million devices since 2021 due to dangerous degradation of sound abatement foam. The FDA has received more than 100,000 reports of problems related to the recall, including at least 385 linked to deaths.

While the company continues to work through its remediation process, more light has been shed on how the recall unfolded as it did. ProPublica and the Pittsburgh Post-Gazette first reported that Philips withheld its CPAP issues from the FDA for years. The reporting later revealed CEO Roy Jakobs’ apparent knowledge of the ongoing issues and alleged approval of the sale of defective devices.

The latest repo…

Read more
  • 0

Philips recalls MRI system due to risk of exploding

[Image courtesy of the FDA/Philips]The FDA says a recall of Philips (NYSE: PHG) + Panorama 1.0T HFO magnetic resonance imaging (MRI) systems is Class I, the most serious kind.

Philips recalled the MRI system due to a risk of explosion during a quench procedure. The excessive pressure buildup of helium gas could cause this.

To date, Philips has received reports of one explosion event in 22 years of use. It reports no injuries or death related to this issue.

There has been one reported event of an explosion in 22 years of use. There have been no reports of injury or death.

During a quench — which Philips said is “not common” — a large amount of helium evaporates and vents outside the building through a venting system. If an unknown blockage is present in the venting system and the pressure exceeds design limits, it could compromise the structural integrity of the system.

Philips says the mag…

Read more
  • 0